40 likes | 142 Views
UTMB Value Analysis Program. Objective: Reduce costs and improve performance through cost-effective utilization and standardization of products/devices, equipment, new technology and related processes while maintaining or improving the quality of patient care. New Value Analysis Structure.
E N D
UTMB Value Analysis Program Objective: Reduce costs and improve performance through cost-effective utilization and standardization of products/devices, equipment, new technology and related processes while maintaining or improving the quality of patient care
New Value Analysis Structure Nursing Products & Routine Consumables Cost Management Team MICU, SICU, BICU, ISCU, Nursing Education, OB/Gyn, Med/Surg, Transplant, Oncology, Hemodialysis, ACE, Pediatric, ED, Clinics, Respiratory, Pathology, TDCJ ICU, TDCJ Med/Surg, TDCJ Clinics, Epidemiology CES, Data & Analytics, Clinical Purchasing, Value Analysis, Materials Management, Administration Supply Management Team CMT Facilitators, Value Analysis, Data & Analytics, Clinical Purchasing, Billing Reimbursement
Product/Equipment Evaluation and Approval Process Phase Requirements Outcomes “DEMO” • Follow vendor policy for appointment and venue • May not be used on patient • Coordinated at Department Level • If an evaluation is desired, follow evaluation process • If not pursuing further, notify vendor “Dog & Pony Show”. Held in Conference/Break Room/Office. No clinical use. Vendor rep may or may not be present. • New Product Request form/cost analysis fully completed and submitted to Value Analysis for O.K. to evaluate • Vendor Release Form Completed • May not be evaluated without V.A. approval • Coordinated at CMT level • “Evaluation” Purchase Order created “EVALUATE” • Request form/cost analysis reviewed at CMT level • Follow decision grid for approvals • Products @ “no charge” or Funding approval required Involves clinical/patient use. Vendor may or may not be present. • Completed evaluation • Cost justified, clinically acceptable • Decision approval @ appropriate Value Analysis level • Request denied may be resubmitted after 12 months • Product added to “Approved Product List” • Coordination with Clinical Purchasing for acquisition • If applicable, discontinue use of product replaced “ACQUIRE” Clinical Evaluation/Cost Analysis completed and product or equipment submitted for Approval.